Cisplatin, cisplatinum, platamin, neoplatin, cismaplat or cis-diamminedichloridoplatinum(II) (CDDP) is a chemotherapy drug. It was the first member of a class of Platinum-containing anti-cancer drugs, which now also includes Carboplatin and Oxaliplatin. These platinum complexes react in the body, binding to DNA and causing the DNA strands to crosslink, which ultimately triggers cells to die in a programmed way. (https://en.wikipedia.org/wiki/Cisplatin)

Incoming Links #

Related Articles (Article 0) #

• Chemotherapy
• Triple-negative breast cancer

Related Medical Scholarly Articles (MedicalScholarlyArticle 1) #

• Triple-negative breast cancer: an unmet medical need

Suggested Pages #

• 0.654 Paclitaxel
• 0.096 Next generation sequencing of triple negative breast cancer to find predictors for chemotherapy response
• 0.084 BCL11A is a triple-negative breast cancer gene with critical functions in stem and progenitor cells
• 0.036 CDK12 Inhibition Reverses De Novo and Acquired PARP Inhibitor Resistance in BRCA Wild-Type and Mutated Models of Triple-Negative Breast Cancer
• 0.033 Copy-number variation
• 0.017 Comparative analysis of algorithms for identifying amplifications and deletions in array CGH data
• 0.013 Genetic alterations of triple negative breast cancer by targeted next-generation sequencing and correlation with tumor morphology
• 0.012 Tumorscape
• 0.012 METABRIC
• 0.012 Allele-specific copy number
• More suggestions...